Does LETERMOVIR Cause Product distribution issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product distribution issue have been filed in association with LETERMOVIR (PREVYMIS). This represents 0.4% of all adverse event reports for LETERMOVIR.
5
Reports of Product distribution issue with LETERMOVIR
0.4%
of all LETERMOVIR reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product distribution issue From LETERMOVIR?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETERMOVIR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LETERMOVIR Cause?
Off label use (277)
Drug ineffective (103)
Product use in unapproved indication (99)
Death (98)
Cytomegalovirus infection reactivation (89)
Cytomegalovirus infection (87)
No adverse event (69)
Hospitalisation (60)
Drug interaction (57)
Pathogen resistance (57)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which LETERMOVIR Alternatives Have Lower Product distribution issue Risk?
LETERMOVIR vs LETROZOLE
LETERMOVIR vs LETROZOLE\RIBOCICLIB
LETERMOVIR vs LEUCOVORIN
LETERMOVIR vs LEUCOVORIN\LEUCOVORIN
LETERMOVIR vs LEUPROLIDE